NCT00085475View on ClinicalTrials.gov

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2007

Conditions

Sarcoma

Interventions

DRUG

imatinib mesylate

PROCEDURE

conventional surgery

Trial Locations (7)

1000

Institut Jules Bordet, Brussels

13385

CHU de la Timone, Marseille

33076

Institut Bergonie, Bordeaux

B-3000

U.Z. Gasthuisberg, Leuven

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

2300 CA

Leiden University Medical Center, Leiden

M20 4BX

Christie Hospital NHS Trust, Manchester

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00085475 - Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma | Biotech Hunter | Biotech Hunter